tiprankstipranks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
TNYA
Tenaya Therapeutics
RESEARCH TOOLSreports

Tenaya Therapeutics (TNYA) Financial Statements

3,120 Followers

Tenaya Therapeutics Financial Overview

Tenaya Therapeutics's market cap is currently $150.73M. The company's EPS TTM is $-0.12; its P/E ratio is -1.20; Tenaya Therapeutics is scheduled to report earnings on March 11, 2026, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -8.44M$ -8.47M$ -8.69M$ -8.71M$ -4.03M
Operating Income$ -93.33M$ -115.95M$ -131.19M$ -125.62M$ -72.81M
EBITDA$ -84.89M$ -102.66M$ -115.40M$ -114.95M$ -68.70M
Net Income$ -90.60M$ -111.13M$ -124.08M$ -123.67M$ -72.72M
Balance Sheet
Cash & Short-Term Investments$ 100.55M$ 61.45M$ 104.64M$ 186.53M$ 251.30M
Total Assets$ 146.92M$ 119.94M$ 170.51M$ 278.94M$ 316.65M
Total Debt$ 10.83M$ 13.61M$ 12.42M$ 15.10M$ 15.70M
Net Debt$ -89.72M$ 9.29M$ -33.26M$ -80.17M$ -22.43M
Total Liabilities$ 23.66M$ 27.09M$ 31.09M$ 35.57M$ 38.12M
Stockholders' Equity$ 123.27M$ 92.85M$ 139.42M$ 243.38M$ 278.53M
Cash Flow
Free Cash Flow$ -68.88M$ -91.53M$ -103.31M$ -125.05M$ -85.93M
Operating Cash Flow$ -68.26M$ -90.50M$ -102.07M$ -104.42M$ -60.81M
Investing Cash Flow$ 56.08M$ 1.13M$ 48.72M$ 83.65M$ -238.56M
Financing Cash Flow$ 108.41M$ 47.75M$ 4.05M$ 77.77M$ 208.97M
Currency in USD

Tenaya Therapeutics Earnings and Revenue History

Income Statement >

Tenaya Therapeutics Debt to Assets

Balance Sheet >

Tenaya Therapeutics Cash Flow

Cash Flow >

Tenaya Therapeutics Forecast EPS vs Actual EPS

Earnings >